PLUS THERAPEUTICS

A glioblastoma is a debilitating brain tumor that currently has no cure. Plus Therapeutics’ mission is to extend the lives of patients with the daunting diagnosis while improving their quality of life.

Specializing in the advancement of targeted radiotherapeutics for cancer treatment, Plus Therapeutics utilizes innovative drug formulations and cutting-edge technologies. Their focus is on developing a new category of radiotherapeutics that can administer a singular, safe, and potent dose of radiation directly to tumors. Overcoming the challenge of delivering substantial doses to tumors while sparing surrounding normal tissue is a primary objective.

Plus Therapeutics’ targeted approach is particularly tailored to address rare and challenging-to-treat cancers in both adults and children. By embracing precision medicine, Plus Therapeutics aspires to safeguard normal cell and tissue functioning, potentially enhancing patient outcomes and quality of life, thereby adding invaluable moments to each individual's life.

They needed a campaign that not only upped their level of sophistication — but more importantly — connected with all audiences in an emotionally powerful way. Our concept was rooted in the value that Plus adds to patients’ lives and modern radiology. Plus is improving on century-old technology in order to lengthen and enhance the final days of patients with difficult, rare cancers. To showcase the emotionality of this impact, we spotlighted imagery of patients enjoying precious moments with their loved ones. The “plus” was featured in the background of images alongside heartwarming copy to highlight that value-add. It’s presence was a symbolic nod to Plus Therapeutic’s scientific impact.